Awen Gallimore

10.3k total citations · 2 hit papers
122 papers, 8.1k citations indexed

About

Awen Gallimore is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Awen Gallimore has authored 122 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Immunology, 36 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Awen Gallimore's work include Immune Cell Function and Interaction (78 papers), T-cell and B-cell Immunology (61 papers) and Immunotherapy and Immune Responses (59 papers). Awen Gallimore is often cited by papers focused on Immune Cell Function and Interaction (78 papers), T-cell and B-cell Immunology (61 papers) and Immunotherapy and Immune Responses (59 papers). Awen Gallimore collaborates with scholars based in United Kingdom, Canada and Switzerland. Awen Gallimore's co-authors include Andrew Godkin, Emma Jones, Rolf M. Zinkernagel, Martin F. Bachmann, Manfred Köpf, Tim Elliott, Hans Hengartner, M. Paula Longhi, Ann Ager and B. Paul Morgan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Awen Gallimore

120 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes

1998 656 citations Awen Gallimore, Andrew Godkin et al. profile →
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1995 633 citations Awen Gallimore et al. profile →

Peers

Countries citing papers authored by Awen Gallimore

Since Specialization

Citations

This map shows the geographic impact of Awen Gallimore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Awen Gallimore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Awen Gallimore more than expected).

Fields of papers citing papers by Awen Gallimore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Awen Gallimore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Awen Gallimore. The network helps show where Awen Gallimore may publish in the future.

Co-authorship network of co-authors of Awen Gallimore

This figure shows the co-authorship network connecting the top 25 collaborators of Awen Gallimore. A scholar is included among the top collaborators of Awen Gallimore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Awen Gallimore. Awen Gallimore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T Cells 2022 ·Cancer Research Communications ·(unknown), Jun Abe, Emma Jones, (unknown), Kathryn Smart, Sarah N. Lauder, Michelle Somerville, Carl F. Ware, Andrew Godkin, Jens V. Stein, Gib Bogle, Awen Gallimore	3
2	Exploiting ECM remodelling to promote immune-mediated tumour destruction 2021 ·Current Opinion in Immunology ·(unknown), Stephanie Burnell, Awen Gallimore	13
3	Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity 2021 ·PubMed ·Stephanie Burnell, (unknown), Bruce J. MacLachlan, (unknown), Awen Gallimore, Andrew Godkin	42
4	Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection 2020 ·Cancer Immunology Research ·(unknown), Alexander Greenshields‐Watson, Emma Jones, Kathryn Smart, Sarah N. Lauder, Michelle Somerville, (unknown), Howard Kendrick, James P. Hindley, Rhiannon French, Matthew J. Smalley, William J. Watkins, Robert Andrews, Andrew Godkin, Awen Gallimore	22
5	Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells 2020 ·Clinical Cancer Research ·Martin Scurr, (unknown), (unknown), Michelle Somerville, Yuan Chen, Sarah L. Hulin-Curtis, Stephanie Burnell, James A. Davies, Michael Davies, Rachel Hargest, Simon Phillips, Adam Christian, Kevin E. Ashelford, Robert Andrews, Alan L. Parker, Richard J. Stanton, Awen Gallimore, Andrew Godkin	3
6	T cell phenotypes in COVID-19 2020 ·Stephanie Hanna, A. A. Codd, Ester Gea‐Mallorquí, (unknown), Felix Clemens Richter, Kristin Ladell, Mariana Borsa, Ewoud B. Compeer, (unknown), (unknown), Sandra Dimonte, (unknown), Frances K. Shepherd, Joseph D. Wilson, (unknown), Awen Gallimore, (unknown)	0
7	Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer 2017 ·Clinical Cancer Research ·Martin Scurr, Tom Pembroke, Anja Bloom, David C. S. Roberts, Amanda Thomson, Kathryn Smart, Hayley Bridgeman, Richard Adams, A. Brewster, Robert H. Jones, Sarah Gwynne, Daniel G. Blount, Richard Harrop, Robert K. Hills, Awen Gallimore, Andrew Godkin	119
8	Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction 2017 ·Cancer Immunology Research ·Emily J. Colbeck, Emma Jones, James P. Hindley, Kathryn Smart, Ralph Schulz, Molly Browne, (unknown), Anwen S. Williams, Lee Parry, Andrew Godkin, Carl F. Ware, Ann Ager, Awen Gallimore	94
9	Escalating Regulation of 5T4-Specific IFN-γ+ CD4+ T Cells Distinguishes Colorectal Cancer Patients from Healthy Controls and Provides a Target for In Vivo Therapy 2013 ·Cancer Immunology Research ·Martin Scurr, Anja Bloom, Tom Pembroke, Rohit Srinivasan, (unknown), Kathryn Smart, Hayley Bridgeman, (unknown), Rachel Hargest, Simon Phillips, Adam Christian, (unknown), Awen Gallimore, Andrew Godkin	15
10	The paradox of NKp46 ⁺ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment 2013 ·Gut ·Tom Pembroke, Adam Christian, Emma Jones, Robert K. Hills, Eddie C. Y. Wang, Awen Gallimore, Andrew Godkin	50
11	T-Cell Trafficking Facilitated by High Endothelial Venules Is Required for Tumor Control after Regulatory T-Cell Depletion 2012 ·Cancer Research ·James P. Hindley, Emma Jones, Kathryn Smart, Hayley Bridgeman, Sarah N. Lauder, Beatrice Ondondo, (unknown), Kristin Ladell, Katherine K. Wynn, David R. Withers, David A. Price, Ann Ager, Andrew Godkin, Awen Gallimore	96
12	Analysis of the T-Cell Receptor Repertoires of Tumor-Infiltrating Conventional and Regulatory T Cells Reveals No Evidence for Conversion in Carcinogen-Induced Tumors 2010 ·Cancer Research ·James P. Hindley, Cristina Ferreira, Emma Jones, Sarah N. Lauder, Kristin Ladell, Katherine K. Wynn, Gareth Betts, Yogesh Singh, David A. Price, Andrew Godkin, Julian Dyson, Awen Gallimore	97
13	Antigen Specificity Determines the Pro- or Antitumoral Nature of CD8+ T Cells 2009 ·The Journal of Immunology ·Simone Cuff, Garry Dolton, R. James Matthews, Awen Gallimore	12
14	CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy? 2009 ·The Journal of Immunology ·Baalasubramanian Sivasankar, M. Paula Longhi, Kathleen Gallagher, Gareth Betts, B. Paul Morgan, Andrew Godkin, Awen Gallimore	44
15	Type I Interferon (IFNα) Acts Directly on Human Memory CD4+ T Cells Altering Their Response to Antigen 2009 ·The Journal of Immunology ·Kathleen Gallagher, Sarah N. Lauder, Ian Rees, Awen Gallimore, Andrew Godkin	35
16	The impact of regulatory T cells on carcinogen-induced sarcogenesis 2007 ·British Journal of Cancer ·Gareth Betts, Jason P. Twohig, Maries van den Broek, Sophie Sierro, Andrew Godkin, Awen Gallimore	56
17	Anti-CD25 antibody enhancement of vaccine-induced immunogenicity to bacterial, viral and parasitic antigens: increased durable cellular immunity with reduced immunodominance 2005 ·Immunology ·Anne Moore, Awen Gallimore, (unknown), (unknown), Sarah C. Gilbert, (unknown)	1
18	The Generation of CD25+CD4+ Regulatory T Cells That Prevent Allograft Rejection Does Not Compromise Immunity to a Viral Pathogen 2005 ·The Journal of Immunology ·Andrew Bushell, Emma Jones, Awen Gallimore, Kathryn J. Wood	53
19	Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression 2003 ·The Journal of Immunology ·Hans Christian Probst, (unknown), Awen Gallimore, Marianne M. Martinic, Michael Basler, Tilman Dumrese, Emma Jones, Maries van den Broek	90
20	Exogenous Peptides Delivered by Ricin Require Processing by Signal Peptidase for Transporter Associated with Antigen Processing-Independent MHC Class I-Restricted Presentation 2002 ·The Journal of Immunology ·Daniel C. Smith, Awen Gallimore, Emma Jones, Brenda Roberts, Janet M. Lord, (unknown), Vincenzo Cerundolo, Lynne M. Roberts	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact